Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

14.22

+0.74 (5.49%)

At close: Oct 8, 2025, 4:00 PM EDT

14.11

-0.11 (-0.77%)

After-hours: Oct 8, 2025, 5:51 PM EDT

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '25 Oct 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	187	78	7	47	191	4,212	Upgrade
Market Cap Growth	1751.75%	965.79%	-84.63%	-75.15%	-95.47%	-77.67%	Upgrade
Enterprise Value	74	-1	-1	52	153	4,180	Upgrade
Last Close Price	14.22	7.43	9.10	1209.61	4895.96	7603.14	Upgrade
PS Ratio	299.54	176.29	3.79	2.63	35.37	628.78	Upgrade
PB Ratio	1.47	0.58	1.00	-4.35	8.27	171.49	Upgrade
P/TBV Ratio	1.99	0.63	-	-	22.11	491.62	Upgrade
EV/Sales Ratio	168.81	-	-	2.87	28.36	624.03	Upgrade
Debt / Equity Ratio	0.01	0.01	0.26	-1.98	1.53	0.06	Upgrade
Asset Turnover	0.00	0.01	0.07	0.32	0.09	0.17	Upgrade
Inventory Turnover	-	-	-	896.21	2444.83	2074.05	Upgrade
Quick Ratio	12.23	19.42	1.64	0.68	2.99	1.53	Upgrade
Current Ratio	12.44	19.95	1.82	0.74	3.11	1.71	Upgrade
Return on Equity (ROE)	-90.25%	-50.06%	-	-684.77%	-354.08%	-282.65%	Upgrade
Return on Assets (ROA)	-32.01%	-29.75%	-53.91%	-32.95%	-82.82%	-74.02%	Upgrade
Return on Capital (ROIC)	-71.73%	-35.69%	-146.88%	-54.11%	-121.58%	-122.42%	Upgrade
Earnings Yield	-24.71%	-45.18%	-432.43%	-87.80%	-44.19%	-1.51%	Upgrade
FCF Yield	-25.35%	-63.10%	-422.75%	-56.58%	-37.19%	-0.96%	Upgrade
Buyback Yield / Dilution	-1182.48%	-2599.19%	-608.45%	-8.32%	-41.86%	-28.52%	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q